Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-19-012552

Options or other derivatives

  • CEO acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Woods Lori A CEO 2019-06-18 Grant or award · Stock Options (right to buy) +250,000 600,000 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…